# HER-2 Protein Vaccine in Treating Women With Breast Cancer

> **NCT00068614** · PHASE1 · COMPLETED · sponsor: **Case Comprehensive Cancer Center**

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** HER-2/neu peptide vaccine

## Key facts

- **NCT ID:** NCT00068614
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2005-10
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2014-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00068614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00068614, "HER-2 Protein Vaccine in Treating Women With Breast Cancer". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT00068614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*